Doxorubicin Hydrochloride liposome (Janssen Products, LP)
Welcome to the PulseAid listing for the Doxorubicin Hydrochloride liposome drug offered from Janssen Products, LP. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Products, LP |
| NON-PROPRIETARY NAME: | doxorubicin hydrochloride |
| SUBSTANCE NAME: | DOXORUBICIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SUSPENSION, LIPOSOMAL |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-06-26 |
| END MARKETING DATE: | 0000-00-00 |
Doxorubicin Hydrochloride liposome HUMAN PRESCRIPTION DRUG Details:
| Item Description | Doxorubicin Hydrochloride liposome from Janssen Products, LP |
| LABELER NAME: | Janssen Products, LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2017-06-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59676-966_2dd41244-8b08-438c-a2e1-df9e704fe8a2 |
| PRODUCT NDC: | 59676-966 |
| APPLICATION NUMBER: | NDA050718 |
Other DOXORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
